The loss of functional myocardial cells in ischemic heart disease is a major cause of subsequent morbidity and mortality. Embryonic stem cells (ESC) have been shown to differentiate into cardiac myocytes and represent a promising potential clinical treatment for ischemic cardiomyopathy. The goal of this proposal is to utilize ESC in a murine model of myocardial injury to demonstrate cardiac engraftment and functional improvement.
The specific aims that will be addressed are as follows: 1. Direct the differentiation of embryonic stem cells toward a ventricular-specific cardiomyocyte phenotype and assess cell survival and myocardial function following intra-myocardial delivery. 2. Determine both cell and recipient therapeutic interventions that may mitigate antigen independent factors causing early ESC death following transplantation. 3. Evaluate imaging modalities to correlate how cell survival parallels with changes in function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL082447-01
Application #
6999118
Study Section
Special Emphasis Panel (ZRG1-DIG-B (21))
Program Officer
Meadows, Tawanna
Project Start
2005-07-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
1
Fiscal Year
2005
Total Cost
$51,548
Indirect Cost
Name
Stanford University
Department
Surgery
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Hendry 2nd, Stephen L; van der Bogt, Koen E A; Sheikh, Ahmad Y et al. (2008) Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells. J Thorac Cardiovasc Surg 136:1028-1037.e1